Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02835196 · ClinicalTrials.gov registry record
Optical Elastography of Systemic Sclerosis Skin
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 12
- Enrollment target
NCT02835196: Completed study, sponsored by The University of Texas Health Science Center, Houston.
NCT02835196 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02835196 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The goal of this study is to develop a new way to assess skin thickness in patients with scleroderma (systemic sclerosis). The study will test how well a new imaging method called optical coherence elastography (OCE) compares to the current clinical method used to estimate skin thickness, the modified Rodnan Skin Score (mRSS).
Interventions
- DEVICE Optical Elastography
- OTHER Visual Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-10-25 |
| Est. Completion | 2018-11-01 |
What the finished NCT02835196 record still lists
NCT02835196 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Optical Elastography is the first listed.
NCT02835196 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02835196 about?
NCT02835196 is a clinical study titled "Optical Elastography of Systemic Sclerosis Skin". The goal of this study is to develop a new way to assess skin thickness in patients with scleroderma (systemic sclerosis). The study will test how well a new imaging method called optical coherence elastography (OCE) compares to the current clinical method used to estimate skin thickness, the modifi...
What is the current status of trial NCT02835196?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2017-10-25. Estimated completion is 2018-11-01.
What interventions are being tested in trial NCT02835196?
The interventions under investigation include: Optical Elastography (DEVICE), Visual Assessment (OTHER).
Who is sponsoring clinical trial NCT02835196?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI